Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Boehringer Ingelheim
Mallinckrodt
AstraZeneca
Dow

Last Updated: January 29, 2022

DrugPatentWatch Database Preview

Claims for Patent: 9,670,262

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,670,262
Title:Modified SAK gene for the production of recombinant proteins
Abstract: The present invention relates to modified SAK gene having amino acid SEQ ID 2. The present invention further relates to process for cloning and expressing modified SAK gene fusion protein which imparts improved stability to the heterologous protein of interest. Further the invention relates to process of purification of recombinant heterologous proteins from bacterial inclusion bodies using modified SAK.
Inventor(s): Salunkhe; Shardul (Maharashtra, IN), Prasad; Bhaskarjyoti (Maharashtra, IN), Muneshwar; Praveen (Maharashtra, IN), Deshpande; Anjali Apte (Maharashtra, IN), Padmanabhan; Sriram (Maharashtra, IN)
Assignee: LUPIN LIMITED (Mumbai, Maharashtra, IN)
Application Number:14/471,400
Patent Claims:1. A process for the preparation of heterologous protein of interest in E. coli comprising the steps of: a) preparing a fusion DNA comprising a first DNA encoding modified SAK protein comprising SEQ ID NO. 2 and a second DNA fused in the frame encoding the heterologous protein of interest, b) cloning of the fusion DNA of step a into an expression vector, c) expressing the fusion protein in E. coli cells, d) optionally refolding and purifying the fusion protein; e) enterokinase cleavage of fusion protein, and f) isolating and purifying the protein of interest to obtain pure heterologous protein.

2. The process as claimed in claim 1, wherein the heterologous protein of interest is parathyroid hormone (1-34).

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKinsey
Colorcon
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.